|
|
Build Your Online Product Catalogs?
| Product Name: |
Nootropic Powder IDRA 21/nootropic@ycgmp.com
|
| Supply Ability: |
500kg/month |
| Related proudcts |
idra 21, |
| Specifications |
99% |
| Price Term: |
CNF |
| Port of loading: |
HK/Shanghai/Shenzhen |
| Minimum Order |
5g |
| Unit Price: |
$1 |
|
IDRA 21
Product Name: IDRA 21
CAS: 22503-72-6
MF: C8H9ClN2O2S
MW: 232.69
Purity: 99%
BP: 405.1°C at 760 mmHg
FP: 198.8°C
Density: 1.394g/cm3
Grade: Pharmaceutical Grade
Appearance: White Powder
IDRA-21 is a relatively new nootropic compound. It works as an a***kine stimulant drug and is currently being researched in regards to its effects in memory improvement, cognitive enhancement, stimulation, and reversing cognitive deficits.
Powerful Drug
IDRA-21 is an a***kine drug derived from benzothiadiazine and a positive allosteric modulator of glutamate A*** receptors. IDRA-21 shows nootropic effects in animal studies, significantly improving learning and memory. It is around 10-30 times more potent than aniracetam in reversing cognitive deficits induced by alprazolam or scopolamine, and produces sustained effects lasting for up to 48 hours after a single dose. The mechanism for this action is thought to be through promoting the induction of long-term potentiation between synapses in the brain.
In co***rison to the benzoylpiperidine derived a***kine drugs, IDRA-21 was more potent than CX-516, but less potent than CX-546. Newer benzothiadiazide derivatives with greatly increased potency co***red to IDRA-21 have been developed, but these have not been researched to the same extent, with the benzoylpiperidine and benzoylpyrrolidine CX-series of drugs being favoured for clinical development, most likely due to more favourable toxicity profiles at high doses.
IDRA-21 Benefits
1. Increase in cognition.
2. Increase Task Accuracy
3. Increases in Short Term Memory
4. Potential Therapeutic Effects On Schizophrenia
5. Potental Therapeutic Effects On Depression
6. Neuroprotection
IDRA-21 Mechanism Of Action
As an A***kine, IDRA-21 works by modulating A*** receptors in the brain. it may prevent A*** receptor desensitization, specifically IDRA-21 binds to the allosteric site of the A*** receptor and induce positive modulation, this is sometimes called allosteric activation.
This propert |
| Company: |
Hangzhou Fuluo Biological Technology Co.,Ltd
|
| Contact: |
Ms. Cindy Lee |
| Address: |
4#Xinfeng Road,Hongjie Street,Jianggan District |
| Postcode: |
310017 |
| Tel: |
86-0571-87963072 |
| Fax: |
86-0571-87963072 |
| E-mail: |
|
|
|
|
Home
